Connecting genomic and proteomic signatures of amyloid burden in the brain.

Autor: Puerta R; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; Universitat de Barcelona (UB)., de Rojas I; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., García-González P; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Olivé C; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain., Sotolongo-Grau O; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain., García-Sánchez A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain., García-Gutiérrez F; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain., Montrreal L; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain., Pablo Tartari J; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain., Sanabria Á; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Pytel V; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Lage C; Neurology Service, Marqués de Valdecilla University Hospital (University of Cantabria and IDIVAL), Santander, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Quintela I; Grupo de Medicina Xenómica, Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII). Universidade de Santiago de Compostela, Santiago de Compostela, Spain., Aguilera N; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain., Rodriguez-Rodriguez E; Neurology Service, Marqués de Valdecilla University Hospital (University of Cantabria and IDIVAL), Santander, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Alarcón-Martín E; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain., Orellana A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Pastor P; Unit of Neurodegenerative diseases, Department of Neurology, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.; The Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain., Pérez-Tur J; Unitat de Genètica Molecular, Institut de Biomedicina de València-CSIC, Valencia, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.; Unidad Mixta de Neurologia Genètica, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Piñol-Ripoll G; Unitat Trastorns Cognitius, Hospital Universitari Santa Maria de Lleida, Lleida, Spain.; Institut de Recerca Biomedica de Lleida (IRBLLeida), Lleida, Spain., de Munian AL; Department of Neurology. Hospital Universitario Donostia. San Sebastian, Spain.; Department of Neurosciences. Faculty of Medicine and Nursery. University of the Basque Country, San Sebastián, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.; Neurosciences Area. Instituto Biodonostia. San Sebastian, Spain., García-Alberca JM; Alzheimer Research Center & Memory Clinic, Andalusian Institute for Neuroscience, Málaga, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Royo JL; Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología. School of Medicine. University of Malaga. Málaga, Spain., Bullido MJ; Centro de Biología Molecular Severo Ochoa (UAM-CSIC).; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.; Instituto de Investigacion Sanitaria 'Hospital la Paz' (IdIPaz), Madrid, Spain.; Universidad Autónoma de Madrid., Álvarez V; Laboratorio de Genética. Hospital Universitario Central de Asturias, Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA)., Real LM; Unidad Clínica de Enfermedades Infecciosas y Microbiología.Hospital Universitario de Valme, Sevilla, Spain.; Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología. School of Medicine. University of Malaga. Málaga, Spain., Anchuelo AC; Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos., Gómez-Garre D; Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos.; Laboratorio de Riesgo Cardiovascular y Microbiota, Hospital Clínico San Carlos; Departamento de Fisiología, Facultad de Medicina, Universidad Complutense de Madrid (UCM).; Biomedical Research Networking Center in Cardiovascular Diseases (CIBERCV), Madrid, Spain., Larrad MTM; Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)., Franco-Macías E; Dementia Unit, Department of Neurology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain., Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Medina M; CIEN Foundation/Queen Sofia Foundation Alzheimer Center.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Sánchez-Valle R; Alzheimer's disease and other cognitive disorders unit. Service of Neurology. Hospital Clínic of Barcelona. Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Dols-Icardo O; Department of Neurology, Sant Pau Memory Unit, Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Sáez ME; CAEBI, Centro Andaluz de Estudios Bioinformáticos, Sevilla, Spain., Carracedo Á; Grupo de Medicina Xenómica, Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII). Universidade de Santiago de Compostela, Santiago de Compostela, Spain.; Fundación Pública Galega de Medicina Xenómica - CIBERER-IDIS, Santiago de Compostela, Spain., Tárraga L; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Alegret M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Valero S; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Marquié M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Boada M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Juan PS; Neurology Service, Marqués de Valdecilla University Hospital (University of Cantabria and IDIVAL), Santander, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Cavazos JE; South Texas Medical Science Training Program, University of Texas Health San Antonio, San Antonio.; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA., Cabrera A; Neuroscience Therapeutic Area, Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Cano A; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Sep 06. Date of Electronic Publication: 2024 Sep 06.